Literature DB >> 26647350

The Associations Between Pre- and Postnatal Maternal Symptoms of Distress and Preschooler's Symptoms of ADHD, Oppositional Defiant Disorder, Conduct Disorder, and Anxiety.

Bothild Bendiksen1,2, Heidi Aase3, Lien My Diep1,2, Elisabeth Svensson4, Svein Friis1,2, Pål Zeiner1.   

Abstract

Objective: The objective of this article is to examine the associations between pre- and postnatal maternal distress and preschooler's symptoms of ADHD, Oppositional Defiant Disorder (ODD), Conduct Disorder (CD), and anxiety, by timing and gender. Method: Children, aged 3.5 years (N = 1,195), recruited from the Norwegian Mother and Child Cohort Study, were assessed with a semistructured parental psychiatric interview. Perinatal maternal symptoms of distress were assessed by Symptom Checklist (SCL-5); Poisson regression was used to examine the associations.
Results: Mid-gestational maternal distress significantly increased the average number of child symptoms, ranging between 3.8% for ADHD hyperactive-impulsive (ADHD-HI) and 8.7% for anxiety. The combination of high maternal scores of distress both pre- and postnatally were associated with increased risk of child symptoms of anxiety (relative risk [RR] = 2.10; 95% confidence interval [CI] = [1.43, 3.07]), CD (RR = 1.83; 95% CI = [1.33, 2.51]), and ODD (RR = 1.30; 95% CI = [1.03, 1.64]), with minor sex differences.
Conclusion: Maternal distress during mid-gestation was associated with ADHD, behavioral, and emotional symptoms in preschool children. Continued exposure into the postnatal period may further increase these risk associations .

Entities:  

Keywords:  ADHD; anxiety; behavioral problems; perinatal distress; preschoolers

Year:  2015        PMID: 26647350     DOI: 10.1177/1087054715616185

Source DB:  PubMed          Journal:  J Atten Disord        ISSN: 1087-0547            Impact factor:   3.256


  7 in total

1.  Maternal anxiety, depression and sleep disorders before and during pregnancy, and preschool ADHD symptoms in the NINFEA birth cohort study.

Authors:  L Vizzini; M Popovic; D Zugna; B Vitiello; M Trevisan; C Pizzi; F Rusconi; L Gagliardi; F Merletti; L Richiardi
Journal:  Epidemiol Psychiatr Sci       Date:  2018-04-18       Impact factor: 6.892

2.  Temperamental and psychomotor predictors of ADHD symptoms in children born after a threatened preterm labour: a 6-year follow-up study.

Authors:  Pablo Navalón; Farah Ghosn; Maite Ferrín; Belén Almansa; Alba Moreno-Giménez; Laura Campos-Berga; Rosa Sahuquillo-Leal; Vicente Diago; Máximo Vento; Ana García-Blanco
Journal:  Eur Child Adolesc Psychiatry       Date:  2022-09-03       Impact factor: 5.349

3.  NICU-based stress response and preterm infant neurobehavior: exploring the critical windows for exposure.

Authors:  Xueying Zhang; Emily Spear; Hsiao-Hsien Leon Hsu; Chris Gennings; Annemarie Stroustrup
Journal:  Pediatr Res       Date:  2022-02-16       Impact factor: 3.953

4.  Prenatal exposure to dental amalgam and risk of symptoms of attention-deficit and hyperactivity disorder (ADHD).

Authors:  Gunvor B Lygre; Heidi Aase; Kjell Haug; Stein A Lie; Lars Björkman
Journal:  Community Dent Oral Epidemiol       Date:  2018-08-07       Impact factor: 3.383

Review 5.  Sex Differences in Vulnerability to Prenatal Stress: a Review of the Recent Literature.

Authors:  Susanna Sutherland; Steven M Brunwasser
Journal:  Curr Psychiatry Rep       Date:  2018-09-18       Impact factor: 5.285

6.  Individual, Prenatal, Perinatal, and Family Factors for Anxiety Symptoms Among Preschool Children.

Authors:  Xiuxiu Ding; Jun Wang; Ning Li; Wanying Su; Hao Wang; Qiuxia Song; Xianwei Guo; Mingming Liang; Qirong Qin; Liang Sun; Mingchun Chen; Yehuan Sun
Journal:  Front Psychiatry       Date:  2021-12-20       Impact factor: 4.157

7.  Early postnatal maternal trait anxiety is associated with the behavioural outcomes of children born preterm <33 weeks.

Authors:  I Kleine; S Falconer; S Roth; S J Counsell; M Redshaw; N Kennea; A D Edwards; C Nosarti
Journal:  J Psychiatr Res       Date:  2020-09-14       Impact factor: 4.791

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.